The European biosimilar market stood at USD 13,864 million in 2024 and is forecasted to reach USD 59,733.3 million by 2033, expanding at a 17.1% CAGR between 2025 and 2033. Market growth is fueled by policy support for biosimilar adoption, advancements in production infrastructure, and consistent technological progress. https://www.imarcgroup.com/europe-biosimilar-market